- Conditions
- Cannabinoid Hyperemesis Syndrome
- Interventions
- Capsaicin, Placebo
- Drug
- Lead sponsor
- University of Virginia
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 1
- States / cities
- Charlottesville, Virginia
Source: ClinicalTrials.gov public record
Updated Oct 17, 2024 · Synced May 22, 2026, 1:18 AM EDT